Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, April 12, 2023
[ Wed, Apr 12th 2023
] - WOPRAI
[ Wed, Apr 12th 2023
] - WOPRAI
[ Wed, Apr 12th 2023
] - WOPRAI
[ Wed, Apr 12th 2023
] - WOPRAI
[ Wed, Apr 12th 2023
] - WOPRAI
[ Wed, Apr 12th 2023
] - WOPRAI
[ Wed, Apr 12th 2023
] - WOPRAI
[ Wed, Apr 12th 2023
] - WOPRAI
[ Wed, Apr 12th 2023
] - WOPRAI
[ Wed, Apr 12th 2023
] - WOPRAI
[ Wed, Apr 12th 2023
] - WOPRAI
[ Wed, Apr 12th 2023
] - WOPRAI
[ Wed, Apr 12th 2023
] - WOPRAI
[ Wed, Apr 12th 2023
] - WOPRAI
[ Wed, Apr 12th 2023
] - WOPRAI
[ Wed, Apr 12th 2023
] - WOPRAI
[ Wed, Apr 12th 2023
] - WOPRAI
[ Wed, Apr 12th 2023
] - WOPRAI
[ Wed, Apr 12th 2023
] - WOPRAI
[ Wed, Apr 12th 2023
] - WOPRAI
[ Wed, Apr 12th 2023
] - WOPRAI
[ Wed, Apr 12th 2023
] - WOPRAI
[ Wed, Apr 12th 2023
] - WOPRAI
[ Wed, Apr 12th 2023
] - WOPRAI
[ Wed, Apr 12th 2023
] - WOPRAI
[ Wed, Apr 12th 2023
] - WOPRAI
[ Wed, Apr 12th 2023
] - WOPRAI
[ Wed, Apr 12th 2023
] - WOPRAI
[ Wed, Apr 12th 2023
] - WOPRAI
[ Wed, Apr 12th 2023
] - WOPRAI
Anupam Rama Maintained (VERA) at Buy with Decreased Target to $22 on, Apr 12th, 2023
Anupam Rama of JP Morgan, Maintained "Vera Therapeutics, Inc." (VERA) at Buy with Decreased Target from $38 to $22 on, Apr 12th, 2023.
Anupam has made no other calls on VERA in the last 4 months.
There are 3 other peers that have a rating on VERA. Out of the 3 peers that are also analyzing VERA, 2 agree with Anupam's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Laura Chico of "Wedbush" Downgraded from Buy to Hold and Held Target at $8 on, Wednesday, January 4th, 2023
- Maury Raycroft of "Jefferies" Downgraded from Strong Buy to Hold and Decreased Target to $6 on, Wednesday, January 4th, 2023
This is the rating of the analyst that currently disagrees with Anupam
- Ed Arce of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $11 on, Wednesday, March 29th, 2023
